-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent Biologics Doses First Patient in Phase 3 Trial of Novel HER2 ADC for Advanced Breast Cancer

Reuters·02/13/2026 00:00:20

Please log in to view news